COST-EFFECTIVENESS ANALYSIS OF VACCINATING AGAINST HERPES ZOSTER WITH ADJUVANTED RECOMBINANT ZOSTER VACCINE IN SWITZERLAND

被引：0
|
作者：
Nishimwe, M. L. [1 ]
Fischer, L. [2 ]
Kientsch, U. [2 ]
Giannelos, N. [3 ]
机构：
[1] AIXIAL GSK, Boulogne, France
[2] GSK, Munchenbuchsee, Switzerland
[3] GSK, Wavre, Belgium
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE94
引用
收藏
页码：S71 / S71
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine
    Good, Chester B.
    Hernandez, Inmaculada
    [J]. JAMA INTERNAL MEDICINE, 2018, 178 (06) : 873 - 873
  • [2] PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF RECOMBINANT ZOSTER VACCINE FOR VACCINATING IMMUNOCOMPROMISED ADULTS AGAINST HERPES ZOSTER IN THE UNITED STATES
    Salem, A.
    Curran, D.
    Carrico, J.
    La, E. M.
    Lorenc, S.
    Hicks, K.
    Poston, S.
    Carpenter, C. F.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S159 - S159
  • [3] Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review
    Giannelos, Nikolaos
    Ng, Cheryl
    Curran, Desmond
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [4] Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
    Le, Phuc
    Rothberg, Michael B.
    [J]. JAMA INTERNAL MEDICINE, 2018, 178 (02) : 248 - 258
  • [5] Cost-Effectiveness Analysis Update of the Adjuvanted Recombinant Zoster Vaccine in Japanese Older Adults
    Lida Teng
    Akiko Mizukami
    Cheryl Ng
    Nikolaos Giannelos
    Desmond Curran
    Tomohide Sato
    Christa Lee
    Taizo Matsuki
    [J]. Dermatology and Therapy, 2022, 12 : 1447 - 1467
  • [6] Cost-Effectiveness Analysis Update of the Adjuvanted Recombinant Zoster Vaccine in Japanese Older Adults
    Teng, Lida
    Mizukami, Akiko
    Ng, Cheryl
    Giannelos, Nikolaos
    Curran, Desmond
    Sato, Tomohide
    Lee, Christa
    Matsuki, Taizo
    [J]. DERMATOLOGY AND THERAPY, 2022, 12 (06) : 1447 - 1467
  • [7] Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States
    Curran, D.
    Patterson, B.
    Varghese, L.
    Van Oorschot, D.
    Buck, P.
    Carrico, J.
    Hicks, K.
    Lee, B.
    Yawn, B.
    [J]. VACCINE, 2018, 36 (33) : 5037 - 5045
  • [8] Cost-effectiveness of an adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease
    Caldera, Freddy
    Spaulding, Aaron C.
    Borah, Bijan
    Moriarty, Jim
    Zhu, Ye
    Hayney, Mary S.
    Farraye, Francis A.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (11) : 1326 - 1334
  • [9] Shingrix - An Adjuvanted, Recombinant Herpes Zoster Vaccine
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1535): : 195 - 196
  • [10] Cost-effectiveness of vaccination against herpes zoster
    de Boer, Pieter T.
    Wilschut, Jan C.
    Postma, Maarten J.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (07) : 2048 - 2061
12345